Jiangsu Nanfang Medical Co., Ltd.
SSE:603880.SS
6.3 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 170.922 | 147.553 | 153.192 | 160.652 | 137.547 | 129.786 | 117.441 | 126.737 | 226.131 | 152.281 | 137.376 | 112.67 | 143.043 | 122.187 | 142.883 | 120.688 | 141.682 | 161.852 | 181.454 | 628.658 | 100.435 | 140.006 | 128.456 | 122.715 | 100.511 | 129.453 | 119.578 | 111.673 | 119.12 | 128.275 | 120.242 | 134.45 | 105.743 | 112.302 | 108.203 | 111.865 | 111.865 |
| Cost of Revenue
| 156.249 | 218.147 | 141.046 | 140.418 | 121.78 | 146.156 | 100.827 | 98.056 | 199.39 | 145.512 | 120.075 | 92.942 | 114.652 | 99.716 | 115.875 | 94.713 | 107.884 | 102.728 | 140.065 | 391.093 | 75.255 | 115.66 | 98.269 | 93.766 | 78.008 | 105.715 | 88.39 | 84.551 | 88.614 | 97.675 | 87.963 | 96.254 | 77.669 | 80.405 | 77.211 | 95.914 | 95.914 |
| Gross Profit
| 14.673 | -70.594 | 12.146 | 20.234 | 15.766 | -16.37 | 16.614 | 28.681 | 26.741 | 6.769 | 17.301 | 19.728 | 28.391 | 22.472 | 27.008 | 25.975 | 33.798 | 59.124 | 41.389 | 237.565 | 25.181 | 24.346 | 30.187 | 28.949 | 22.503 | 23.737 | 31.187 | 27.122 | 30.507 | 30.599 | 32.279 | 38.196 | 28.074 | 31.898 | 30.992 | 15.951 | 15.951 |
| Gross Profit Ratio
| 0.086 | -0.478 | 0.079 | 0.126 | 0.115 | -0.126 | 0.141 | 0.226 | 0.118 | 0.044 | 0.126 | 0.175 | 0.198 | 0.184 | 0.189 | 0.215 | 0.239 | 0.365 | 0.228 | 0.378 | 0.251 | 0.174 | 0.235 | 0.236 | 0.224 | 0.183 | 0.261 | 0.243 | 0.256 | 0.239 | 0.268 | 0.284 | 0.265 | 0.284 | 0.286 | 0.143 | 0.143 |
| Reseach & Development Expenses
| 6.177 | 5.877 | 8.126 | 7.957 | 6.653 | 7.785 | 5.58 | 6.502 | 8.314 | 5.391 | 7.486 | 7.578 | 7.271 | 7.8 | 8.911 | 6.334 | 7.578 | 13.644 | 9.326 | 7.283 | 3.71 | 5.577 | 5.66 | 6.412 | 4.651 | 5.43 | 6.658 | 4.509 | 3.493 | 4.869 | 5.545 | 9.498 | 0 | 18.822 | 0 | 0 | 0 |
| General & Administrative Expenses
| 11.925 | 11.292 | 33.647 | -5.738 | 10.823 | -21.722 | 32.809 | -5.835 | 12.758 | -16.561 | 27.274 | -4.173 | 9.429 | -13.294 | 25.689 | 1.721 | 15.181 | -12.856 | 11.069 | -0.592 | 8.05 | -9.735 | 9.137 | -2.282 | 5.995 | -6.557 | 8.639 | -5.821 | 10.341 | -25.385 | 13.192 | 11.399 | 11.601 | -23.994 | 13.335 | 0 | 0 |
| Selling & Marketing Expenses
| 0.829 | 3.188 | 2.634 | 0.659 | 1.747 | 3.827 | 1.343 | 0.734 | 1.824 | 2.243 | 2.597 | 1.134 | 1.216 | 4.398 | 1.652 | 1.637 | 1.476 | -19.26 | 2.367 | 131.056 | 2.289 | 3.264 | 3.246 | 2.886 | 2.481 | 3.002 | 5.245 | 2.968 | 2.452 | 6.694 | 2.657 | 1.941 | 1.901 | 2.716 | 1.642 | 0 | 0 |
| SG&A
| 12.753 | 14.48 | 36.281 | 7.158 | 12.272 | -17.895 | 34.152 | -5.101 | 14.582 | -14.318 | 29.871 | -3.038 | 10.645 | -8.896 | 27.341 | 3.358 | 16.657 | -32.115 | 13.436 | 130.464 | 10.339 | -6.472 | 12.383 | 0.604 | 8.476 | -3.555 | 13.884 | -2.852 | 12.793 | -18.691 | 15.849 | 13.341 | 13.502 | -21.278 | 14.978 | 0 | 0 |
| Other Expenses
| 3.765 | 97.438 | -18.391 | -2.021 | 2.986 | -1.546 | -0.181 | -0.155 | 1.257 | 34.266 | -13.739 | 15.216 | 0.685 | -1.43 | -0.004 | -1.177 | -0.001 | 8.454 | -0.1 | -0.001 | -0.15 | 2.56 | 0.053 | 0.018 | 0.018 | -0.824 | -0.046 | 0.116 | -0.005 | -1.759 | 1.21 | -0.415 | 0.376 | 0.381 | 0.976 | 0 | 0 |
| Operating Expenses
| 22.696 | 117.794 | 26.016 | 17.136 | 15.939 | 24.229 | 19.713 | 24.045 | 24.152 | 25.339 | 23.618 | 19.756 | 18.601 | 32.402 | 25.208 | 22.219 | 24.949 | 10.091 | 27.854 | 152.844 | 14.652 | 19.637 | 19.207 | 16.742 | 13.538 | 22.738 | 21.76 | 16.06 | 12.983 | 22.673 | 16.897 | 14.499 | 14.564 | 18.756 | 15.943 | 0.009 | 0.009 |
| Operating Income
| -8.023 | -188.388 | -14.668 | 3.097 | -0.173 | -154.367 | -1.228 | 0.854 | 7.92 | -36.809 | -4.973 | 1.559 | 7.44 | -47.284 | 5.511 | 4.834 | 8.866 | -0.763 | 7.996 | 84.028 | 10.422 | -11.324 | 10.575 | 15.422 | 10.73 | -13.76 | 14.587 | 30.806 | 13.69 | 4.471 | 13.162 | 19.393 | 12.687 | 16.25 | 12.493 | 15.951 | 15.951 |
| Operating Income Ratio
| -0.047 | -1.277 | -0.096 | 0.019 | -0.001 | -1.189 | -0.01 | 0.007 | 0.035 | -0.242 | -0.036 | 0.014 | 0.052 | -0.387 | 0.039 | 0.04 | 0.063 | -0.005 | 0.044 | 0.134 | 0.104 | -0.081 | 0.082 | 0.126 | 0.107 | -0.106 | 0.122 | 0.276 | 0.115 | 0.035 | 0.109 | 0.144 | 0.12 | 0.145 | 0.115 | 0.143 | 0.143 |
| Total Other Income Expenses Net
| 0.003 | -0.381 | -2.328 | -3.474 | 2.083 | -1.546 | 0 | -0.155 | 0.003 | 0.145 | -0.1 | -2.231 | 0 | -1.43 | -0.004 | -1.177 | -0.001 | 8.454 | -0.1 | -0.001 | -0.15 | 2.56 | 0.053 | 0.018 | 0.018 | -0.824 | -0.046 | 0.116 | -0.005 | -1.745 | 0.211 | 0.116 | 0.376 | 0.189 | 0.976 | -0.009 | -0.009 |
| Income Before Tax
| -8.019 | -188.769 | -16.996 | -2.252 | -0.076 | -155.913 | -1.228 | 0.699 | 7.923 | -36.663 | -0.449 | 0.328 | 7.44 | -48.714 | 5.506 | 3.656 | 8.866 | 7.692 | 7.896 | 84.027 | 10.271 | -8.765 | 10.627 | 15.44 | 10.748 | -14.583 | 14.541 | 30.922 | 13.685 | 2.725 | 14.371 | 19.51 | 13.062 | 16.439 | 13.469 | 15.942 | 15.942 |
| Income Before Tax Ratio
| -0.047 | -1.279 | -0.111 | -0.014 | -0.001 | -1.201 | -0.01 | 0.006 | 0.035 | -0.241 | -0.003 | 0.003 | 0.052 | -0.399 | 0.039 | 0.03 | 0.063 | 0.048 | 0.044 | 0.134 | 0.102 | -0.063 | 0.083 | 0.126 | 0.107 | -0.113 | 0.122 | 0.277 | 0.115 | 0.021 | 0.12 | 0.145 | 0.124 | 0.146 | 0.124 | 0.143 | 0.143 |
| Income Tax Expense
| -0.134 | -11.156 | 0.182 | 0.452 | 0.158 | -1.194 | -0.698 | -0.35 | 1.012 | -14.077 | -1.259 | 0.092 | 0.838 | -11.157 | 2.082 | 1.542 | -0.115 | 2.039 | -1.257 | 9.839 | 0.982 | -1.69 | 1.107 | 2.15 | 1.333 | -0.198 | 1.587 | 4.737 | 1.632 | -2.917 | 1.396 | 3.292 | 1.472 | 1.402 | 2.467 | 2.943 | 2.943 |
| Net Income
| -7.918 | -177.356 | -14.34 | -0.719 | 1.745 | -154.68 | -0.638 | 0.97 | 6.931 | -22.586 | 0.902 | 0.236 | 6.727 | -37.501 | 3.522 | 2.088 | 9.128 | 6.173 | 8.679 | 73.783 | 9.433 | -5.159 | 10.131 | 13.777 | 9.302 | -13.255 | 14.059 | 26.241 | 12.204 | 6.484 | 13.291 | 16.247 | 11.58 | 15.003 | 10.949 | 13.014 | 13.014 |
| Net Income Ratio
| -0.046 | -1.202 | -0.094 | -0.004 | 0.013 | -1.192 | -0.005 | 0.008 | 0.031 | -0.148 | 0.007 | 0.002 | 0.047 | -0.307 | 0.025 | 0.017 | 0.064 | 0.038 | 0.048 | 0.117 | 0.094 | -0.037 | 0.079 | 0.112 | 0.093 | -0.102 | 0.118 | 0.235 | 0.102 | 0.051 | 0.111 | 0.121 | 0.11 | 0.134 | 0.101 | 0.116 | 0.116 |
| EPS
| -0.027 | -0.609 | -0.05 | -0.003 | 0.006 | -0.54 | -0.002 | 0.003 | 0.024 | -0.078 | 0.003 | 0.001 | 0.023 | -0.15 | 0.012 | 0.007 | 0.031 | 0.021 | 0.029 | 0.26 | 0.032 | -0.018 | 0.033 | 0.047 | 0.033 | -0.045 | 0.047 | 0.09 | 0.055 | 0.027 | 0.077 | 0.074 | 0.053 | 0.072 | 0.053 | 0.061 | 0.061 |
| EPS Diluted
| -0.027 | -0.609 | -0.05 | -0.003 | 0.006 | -0.54 | -0.002 | 0.003 | 0.024 | -0.078 | 0.003 | 0.001 | 0.023 | -0.15 | 0.012 | 0.007 | 0.031 | 0.021 | 0.029 | 0.26 | 0.032 | -0.018 | 0.033 | 0.047 | 0.033 | -0.043 | 0.047 | 0.09 | 0.055 | 0.027 | 0.077 | 0.074 | 0.053 | 0.072 | 0.053 | 0.061 | 0.061 |
| EBITDA
| -2.307 | -170.381 | -12.542 | 17.268 | 14.844 | -128.024 | 12.711 | 17.884 | 21.097 | -18.616 | 2.238 | 11.111 | 20.353 | -35.41 | 14.147 | 10.349 | 15.633 | 9.958 | 9.854 | 89.332 | 16.202 | -2.457 | 13.717 | 19.257 | 12.69 | 5.81 | 21.75 | 17.187 | 16.249 | 6.869 | 16.078 | 226.683 | 13.509 | 16.378 | 15.917 | 17.419 | 17.419 |
| EBITDA Ratio
| -0.013 | -1.155 | -0.082 | 0.107 | 0.108 | -0.986 | 0.108 | 0.141 | 0.093 | -0.122 | 0.016 | 0.099 | 0.142 | -0.29 | 0.099 | 0.086 | 0.11 | 0.062 | 0.054 | 0.142 | 0.161 | -0.018 | 0.107 | 0.157 | 0.126 | 0.045 | 0.182 | 0.154 | 0.136 | 0.054 | 0.134 | 1.686 | 0.128 | 0.146 | 0.147 | 0.156 | 0.156 |